Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
Pernicious anemia occurs when the body lacks intrinsic factor, a protein needed to absorb vitamin B12 from food
Formulation differences: do they change the risk
Concerned about side effects
Just 1015 minutes of exposure can provide up to 10,000 IU of vitamin D3, supporting bone health and immune function
US$ 20.80
US$ 20.26
US$ 28.12
US$ 20.09
US$ 21.00
US$ 20.70
US$ 22.73
US$ 27.74
US$ 23.66
US$ 26.66
US$ 21.13
US$ 21.92
